Citation: | Deng Feiwen, Chen Huanwei, Zhen Zuojun, et al. Short-term clinical efficacy of liver transplantation with organs from donation after Chinese citizens' death in patients with high model for end-stage liver disease score[J]. ORGAN TRANSPLANTATION, 2015, 6(2): 86-92. doi: 10.3969/j.issn.1674-7445.2015.02.004 |
[1] |
Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant:strengths and weaknesses[J]. J Hepatol, 2011, 54(6):1297-1306. doi: 10.1016/j.jhep.2010.11.008
|
[2] |
David AI, Coelho MP, Paes AT, et al. Liver transplant outcome:a comparison between high and low MELD score recipients[J]. Einstein, 2012, 10(1):57-61. doi: 10.1590/S1679-45082012000100012
|
[3] |
李瑞东, 马钧, 张磊, 等.原位肝移植受者术后早期急性呼吸窘迫综合征的相关危险因素分析[J].中华器官移植杂志, 2013, 34(12):723-727. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201312006
Li RD, Ma J, Zhang L, et al. The related perioperative risk factors of early acute lung injury after orthotopic liver transplantation[J]. Chin J Organ Transplant, 2013, 34(12):723-727. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201312006
|
[4] |
Hong G, Lee KW, Suh S, et al. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation[J]. J Korean Med Sci, 2013, 28(8):1207-1212. doi: 10.3346/jkms.2013.28.8.1207
|
[5] |
Francoz C, Belghiti J, Castaing D, et al. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system[J]. Liver Transpl, 2011, 17(10):1137-1151. doi: 10.1002/lt.v17.10
|
[6] |
Suzuki H, Bartlett AS, Muiesan P, et al. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation[J]. Transplant Proc, 2012, 44(2):384-388. doi: 10.1016/j.transproceed.2011.11.013
|
[7] |
Selzner M, Kashfi A, Cattral MS, et al. Live donor liver transplantation in high MELD score recipients[J]. Ann Surg, 2010, 251(1):153-157. doi: 10.1097/SLA.0b013e3181bc9c6a
|
[8] |
Li H, Li B, Wei Y, et al. Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores:a single center experience[J]. PLoS One, 2013, 8(9):e74081. doi: 10.1371/journal.pone.0074081
|
[9] |
Chok KSh, Chan SC, Fung JY, et al. Survival outcomes of right-lobe living donor liver transplantation for patients with high model for end-stage liver disease scores[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(3):256-262. doi: 10.1016/S1499-3872(13)60042-9
|
[10] |
Poon KS, Chen TH, Jeng LB, et al. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation[J]. Transplant Proc, 2012, 44(2):316-319. doi: 10.1016/j.transproceed.2012.02.006
|
[11] |
Sharma P, Schaubel DE, Gong Q, et al. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates[J]. Hepatology, 2012, 55(1):192-198. doi: 10.1002/hep.24632
|
[12] |
Alexopoulos S, Matsuoka L, Cho Y, et al. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher[J]. Transplantation, 2013, 95(3):507-512. doi: 10.1097/TP.0b013e3182751ed2
|
[13] |
Oberkofler CE, Dutkowski P, Stocker R, et al. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients[J]. Crit Care, 2010, 14(3):R117. doi: 10.1186/cc9068
|
[14] |
胡月云, 刘波, 颜君, 等.APACHE Ⅳ评分和MELD评分对肝移植术后患者死亡分辨能力研究[J/CD].中华肝脏外科手术学电子杂志, 2013, 2(5):314-317. http://d.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201305010
Hu YY, Liu B, Yan J, et al. Discriminability of acute physiology and chronic health evaluation Ⅳ and model for end-stage liver disease scores on mortality after lisease scores on mortality after liver transplantation[J/CD]. Chin J Hepat Surg:Electr Edit, 2013, 2(5):314-317. http://d.wanfangdata.com.cn/Periodical/zhgzwkssxdzzz201305010
|
[15] |
Perry DK, Willingham DL, Sibulesky L, et al. Should donation after cardiac death liver grafts be used for retransplantation?[J]. Ann Hepatol, 2011, 10(4):482-485. https://www.researchgate.net/publication/51632120_Should_donation_after_cardiac_death_liver_grafts_be_used_for_retransplantation
|
[16] |
Testro AG, Visvanathan K, Skinner N, et al. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4[J]. J Gastroenterol Hepatol, 2011, 26(1):155-163. doi: 10.1111/jgh.2011.26.issue-1
|
[17] |
任贵军, 滕亮, 曹经琳, 等.老年肝移植受者围手术期处理12例[J].中华器官移植杂志, 2013, 34(12):716-719. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201312004
Ren GJ, Teng L, Cao JL, et al. Perioperative treatment of liver transplantation in elder recipients:a report of 12 cases[J]. Chin J Organ Transplant, 2013, 34(12):716-719. http://d.wanfangdata.com.cn/Periodical/zhqgyz98201312004
|
[18] |
Feltracco P, Carollo C, Barbieri S, et al. Early respiratory complications after liver transplantation[J]. World J Gastroenterol, 2013, 19(48):9271-9281. doi: 10.3748/wjg.v19.i48.9271
|